Myocardial dysfunction of CRF dialysis patients over 55 Report II. Characteristic features of the congestive heart failure (CHF) development in elderly patients. Haemodialysis and CHF effect on the circulation state in main vessels of the brain
Abstract
Peculiarities of CHF development and its influence on the regional cerebral bloodflow in 47 patients older than 55 (range 55-73) were studied to increase the efficacy of haemodialysis treatment, its quality and prolongation of the life period in elderly ESRD patients. Multiple factors such as age, anemia, diabetes mellitus, IHD, hypoalbuminaemia, transformation of the left ventricular hypertrophy into dilatory cardiomyopathy are stated to effect upon the rise and progression of the congestive heart failure resulting systolic myocardial dysfunction. CHF development is an unfavorable factor to prognose the life span of the dialysis patients. Long-term treated by the program haemodialysis. Sufficient abnormalities of the circulation in cerebral vessels were revealed which cause the dyscirculatory encephalopathy and explain the rise of the orthostatic reaction following the haemodialysis procedure.
About the Authors
A. P. Ilyin
Кафедра терапии и семейной медицины Казанской медицинской академии; ГУЗ ОКБ, г. Ульяновск
Russian Federation
Russian Federation
B. F. Bogoyavlensky
Кафедра терапии и семейной медицины Казанской медицинской академии; ГУЗ ОКБ, г. Ульяновск
Russian Federation
Russian Federation
R. M. Gazizov
Кафедра терапии и семейной медицины Казанской медицинской академии; ГУЗ ОКБ, г. Ульяновск
Russian Federation
Russian Federation
I. V. Poletaev
Кафедра терапии и семейной медицины Казанской медицинской академии; ГУЗ ОКБ, г. Ульяновск
Russian Federation
Russian Federation
References
1. Лелюк В.Г., Лелюк С.Э. Ультразвуковая ангиология. - М.: Реальное время, 1999. - 288 с.
2. Agodoa I.Y., Eggers P.W. Renal replacement therapy in the United States: data from the United States renal data system // Am J Kidney Dial. 1995; 29: 119-133.
3. Foley R.N., Culleton B.F., Parfrey P.S. et al. Cardiac disease in diabetic end-stage renal disease // Diabetologia. 1997; 40: 1307-1312.
4. Harnett J.D., Parfrey P.S. Left ventricular dysfunction in dialysis patients. In: Henrich W.L. (ed). Principles and practice of dialysis. Williams & Willkins. Baltimore. 1994: 170-180.
5. London G.M., Drueke T.B. Atherosclerosis and arteriosclerosis in chronic renal failure // Kidney Int. 1997; 51: 1678-1695.
6. Murphy S.W., Parfrey P.S., Folley R.N. Screening and threatment for cardiovascular disease in patients with chronic renal disease // Am J Kidney Dis. 1998; 32; Suppl. 3: 184-199.
7. Parfrey P.S., Foley R.N., Harnett J.D. et al. The outcome and risk factors for left ventricular disorders in chronic uremia // Nephrol. Dial Transplant. 1996; 11: 1277-1285.
8. Teraoka S., Toma H., Nibei H. et al. Current status of renal replacement therapy in Japan // Amer. J. Kidney Dis. 1995; 25: 151-164.
Review
For citations:
Ilyin A.P., Bogoyavlensky B.F., Gazizov R.M., Poletaev I.V. Myocardial dysfunction of CRF dialysis patients over 55 Report II. Characteristic features of the congestive heart failure (CHF) development in elderly patients. Haemodialysis and CHF effect on the circulation state in main vessels of the brain. Nephrology and Dialysis. 2001;3(3):370-373. (In Russ.)
Views:
1
Email this article 